Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase
2020
Itaconate is a mammalian antimicrobial metabolite that inhibits the isocitrate lyases (ICLs) of Mycobacterium tuberculosis. Herein, we report that ICLs form a covalent adduct with itaconate through their catalytic cysteine residue. These results reveal atomic details of itaconate inhibition and provide insights into the catalytic mechanism of ICLs.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
5
Citations
NaN
KQI